Glazer Capital, LLC
Glazer Capital, LLC is a hedge fund and investment management firm headquartered in Stamford, Connecticut, United States. Founded by Paul J. Glazer, the firm specializes in event-driven investment strategies and manages assets for high-net-worth individuals, family offices, and institutional investors. The firm has a longstanding history of leveraging fundamental research to capitalize on merger arbitrage and other special situations opportunities across global markets.
Investment Strategy
Glazer Capital, LLC focuses primarily on event-driven investment strategies, with a strong emphasis on merger arbitrage and special situations globally. The firm employs both fundamental and quantitative research to identify opportunities presented by corporate actions, such as mergers, spin-offs, and restructurings. Glazer Capital aims to generate consistent, risk-adjusted returns by exploiting pricing inefficiencies before and after significant corporate events, while maintaining disciplined risk management.
Latest 13F Filing Activity
Glazer Capital, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 126 equity positions and 5 options positions with a total 13F market value of $3B. The fund increased holdings in Springworks Therapeutics Inc., Blueprint Medicines Corp., Enstar Group Limited among other positions. Glazer Capital, LLC reduced exposure to Intra-cellular Therapies Inc., Patterson Cos Inc., Air Transport Services GRP I among others.
Top Holdings
Equity Positions (126)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
E ESGR | ENSTAR GROUP LIMITED | 8.67% | $242.5M | 721,000 | $331.28 | $336.36 | +$158.6M |
S SWTX | SPRINGWORKS THERAPEUTICS INC | 6.90% | $193.0M | 4,107,199 | $46.99 | $46.99 | +$193.0M |
B BPMC | BLUEPRINT MEDICINES CORP | 6.10% | $170.6M | 1,331,300 | $128.18 | $128.18 | +$170.6M |
D DNB | DUN & BRADSTREET HLDGS INC | 5.79% | $161.8M | 17,804,631 | $9.06 | $9.09 | +$131.5M |
S SKX | SKECHERS U S A INC | 5.40% | $151.0M | 2,393,675 | $63.10 | $63.10 | +$151.0M |
Options Positions (5)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
K K | KELLANOVA | New | Put | $454.0K | 40 | $79.53 | $79.53 | +39.51 | +$454.0K |
S SKX | SKECHERS U S A INC | New | Call | $24.0K | 21 | $63.10 | $63.10 | +20.58 | +$24.0K |
H HIMS | HIMS & HERS HEALTH INC | New | Put | $14.0K | 5 | $49.85 | $49.85 | +5 | +$14.0K |
F FYBR | FRONTIER COMMUNICATIONS PARE | — | Put | $8.0K | 2 | $36.40 | $35.52 | 0 | -$19.0K |
T TGI | TRIUMPH GROUP INC NEW | New | Put | $6.0K | 1 | $25.75 | $25.74 | +0.57 | +$6.0K |
Industry Allocation
Investment Team (11)
| Name | Role | Location | |
|---|---|---|---|
 | Sr. Trading Analyst | New York, NY , United States | |
A Austin Dunn | Research Analyst | New York, NY , United States | |
 | Managing Director (Convertibles) | New York, NY , United States | |
M Mark Ort | Portfolio Manager | New York, NY , United States | |
O Omari Ramirez | Research Analyst | New York, NY , United States | |
P Peter Baldino | Research Analyst | New York, NY , United States | |
 | Junior Analyst | New York, NY , United States | |
 | Research Analyst | New York, NY , United States | |
 | Senior Research Analyst | New York, NY , United States | |
 | Senior Research Analyst | London, United Kingdom |